Market Research Logo

Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2017

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Peripheral Embolic Protection Devices Overview
3 Products under Development
3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment
3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory
3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials
4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies
4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
5 Peripheral Embolic Protection Devices Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Avantec Vascular Corporation Company Overview
5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.3 BTG Plc Company Overview
5.3.1 BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardio-Flow Ltd. Company Overview
5.4.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 CardioGard Ltd. Company Overview
5.5.1 CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.6 EMBA Medical Limited Company Overview
5.6.1 EMBA Medical Limited Pipeline Products & Ongoing Clinical Trials Overview
5.7 Emboline, Inc. Company Overview
5.7.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Filterlex Medical Ltd Company Overview
5.8.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Inari Medical, Inc. Company Overview
5.9.1 Inari Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Innovative Cardiovascular Solutions, LLC Company Overview
5.10.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Innovia LLC Company Overview
5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Keystone Heart Ltd Company Overview
5.12.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Medtronic plc Company Overview
5.13.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Metactive Medical LLC Company Overview
5.14.1 Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 MIV Therapeutics Inc Company Overview
5.15.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Neurosonix Ltd. Company Overview
5.16.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.17 Shape Memory Therapeutics, Inc. Company Overview
5.17.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 Trinity College Dublin Company Overview
5.18.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Minnesota Company Overview
5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Toledo Company Overview
5.20.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
6 Peripheral Embolic Protection Devices- Recent Developments
6.1 Jul 05, 2017: Penumbra Promotes Daniel Davis to Chief Commercial Officer
6.2 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.3 Jun 16, 2017: ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
6.4 Jun 16, 2017: Sentinel Cerebral Protection System Used Commercially By TAVR Centers of Excellence Nationwide
6.5 Jun 05, 2017: Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.
6.6 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.7 May 22, 2017: OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS Therapy For Pulmonary Embolism
6.8 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results
6.9 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
6.10 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results
6.11 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors
6.12 Apr 11, 2017: Testing Device Aimed at Reducing Stroke Risk During Transcatheter Aortic Valve Replacement
6.13 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results
6.14 Mar 30, 2017: MPSC Announces 2016 Annual Results
6.15 Mar 21, 2017: Metactive Medical Announces Issuance of Patent on Blockstent Embolization Device
6.16 Mar 15, 2017: Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of EMBLOK Embolic Protection System
6.17 Mar 02, 2017: Penumbra Announces Key Events at Society of Interventional Radiology 2017 Meeting
6.18 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results
6.19 Feb 27, 2017: FDA Advisory Committee Strongly Supports Granting de novo Application for the First Cerebral Protection System for Transcatheter Aortic Valve Replacement
6.20 Feb 27, 2017: BTG Receives U.S. FDA 510(k) Clearance For EKOS Control Unit 4.0
6.21 Feb 27, 2017: Keystone Heart Applauds FDA Advisory Panel for Recognition of The Need for Cerebral Protection Following TAVR
6.22 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.23 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.24 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
6.25 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results
6.26 Jan 09, 2017: First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS system
6.27 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results
6.28 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors
6.29 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.30 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.31 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.32 Nov 15, 2016: Penumbra Announces Resignation of Board Member
6.33 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.34 Nov 10, 2016: Penumbra to Highlight Peripheral Vascular Technologies at AIMsymposium and VEITHsymposium in New York
6.35 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members
6.36 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results
6.37 Nov 01, 2016: Results from U.S. Pivotal IDE Trial Show That Sentinel Cerebral Protection System Protects Patients During Transcatheter Aortic Valve Replacement
6.38 Nov 01, 2016: Delirium Significantly Associated with Brain Lesions in Patients Post-TAVR According to New Data Released at TCT 2016
6.39 Oct 28, 2016: Emboline’s “enabling TAVI” aortic embolic protection technology is selected for presentation at TCT 2016
6.40 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
6.41 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results
6.42 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
6.43 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results
6.44 Oct 03, 2016: American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR
6.45 Sep 20, 2016: Claret Medical Submits Marketing Application to FDA for US Clearance of First Cerebral Protection System for Transcatheter Aortic Valve Replacement (TAVR)
6.46 Sep 19, 2016: TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures
6.47 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
6.48 Sep 14, 2016: Claret Medical Announces SENTINEL Pivotal IDE Trial to Be Featured in Late-Breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference
6.49 Aug 30, 2016: MPSC Announces 2016 Interim Results
6.50 Aug 25, 2016: Medtronic Reports First Quarter Financial Results
6.51 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results
6.52 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
6.53 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results
6.54 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials
Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Peripheral Embolization Device - Product Status
Table 14: Peripheral Embolization Device - Product Description
Table 15: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: EkoSonic Endovascular System - Product Status
Table 17: EkoSonic Endovascular System - Product Description
Table 18: BTG Plc - Ongoing Clinical Trials Overview
Table 19: EkoSonic Endovascular System - Submassive Pulmonary Embolism Experience with EKOS
Table 20: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 21: EmboPRO EPD - Product Status
Table 22: EmboPRO EPD - Product Description
Table 23: CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: CardioGard 22 French Aortic Cannula - Product Status
Table 25: CardioGard 22 French Aortic Cannula - Product Description
Table 26: CardioGard Ltd. - Ongoing Clinical Trials Overview
Table 27: CardioGard 22 French Aortic Cannula - A Study to Collect Additional Information Related to the Performance of the CARDIOGARD Cannula
Table 28: EMBA Medical Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Hourglass Peripheral Embolization Plug - Product Status
Table 30: Hourglass Peripheral Embolization Plug - Product Description
Table 31: Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Emboliner - Product Status
Table 33: Emboliner - Product Description
Table 34: Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Next Generation Embolic Protection Device - Product Status
Table 36: Next Generation Embolic Protection Device - Product Description
Table 37: Inari Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 38: FlowTriever System - Pulmonary Embolism - Product Status
Table 39: FlowTriever System - Pulmonary Embolism - Product Description
Table 40: Inari Medical, Inc. - Ongoing Clinical Trials Overview
Table 41: FlowTriever System - Pulmonary Embolism - FlowTriever Pulmonary Embolectomy Clinical Study
Table 42: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 43: EMBLOK Embolic Protection System - Product Status
Table 44: EMBLOK Embolic Protection System - Product Description
Table 45: Innovative Cardiovascular Solutions, LLC - Ongoing Clinical Trials Overview
Table 46: EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
Table 47: EMBLOK Embolic Protection System - Safety and Efficacy of EMBLOK Embolic Protection System in Patients with Severe Aortic Stenosis
Table 48: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Permanently Implantable Embolic Balloon - Product Status
Table 50: Permanently Implantable Embolic Balloon - Product Description
Table 51: Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 52: TriGuard Cerebral Protection Device - Product Status
Table 53: TriGuard Cerebral Protection Device - Product Description
Table 54: Keystone Heart Ltd - Ongoing Clinical Trials Overview
Table 55: TriGuard Cerebral Protection Device - A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
Table 56: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: SilverHawk With SpiderFX Embolic Protection Device - Product Status
Table 58: SilverHawk With SpiderFX Embolic Protection Device - Product Description
Table 59: Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Blockstent Microcatheter - Product Status
Table 61: Blockstent Microcatheter - Product Description
Table 62: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Aortic Embolic Protection Device - Product Status
Table 64: Aortic Embolic Protection Device - Product Description
Table 65: Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Protection Collar - Product Status
Table 67: Protection Collar - Product Description
Table 68: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Peripheral Vascular Embolization System - Product Status
Table 70: Peripheral Vascular Embolization System - Product Description
Table 71: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Transcatheter Device - Atherosclerotic Plaque - Product Status
Table 73: Transcatheter Device - Atherosclerotic Plaque - Product Description
Table 74: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Embolic Protection Device - Product Status
Table 76: Embolic Protection Device - Product Description
Table 77: University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Minimally Invasive Thrombectomy Device - Product Status
Table 79: Minimally Invasive Thrombectomy Device - Product Description
Table 80: Glossary
1.2 List of Figures
Figure 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Figure 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Figure 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Figure 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Figure 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Figure 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials

Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2017 provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Embolic Protection Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;